Research Overview: Zhewitra-40 Sunrise
Zhewitra-40 Sunrise is a pharmaceutical-grade vardenafil preparation manufactured by Sunrise Pharmaceuticals for laboratory research applications. Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that selectively targets this enzyme to modulate cyclic guanosine monophosphate (cGMP) pathways in vascular tissue research. This compound is exclusively available from Stroid UK Shop for qualified research institutions examining cardiovascular and erectile dysfunction mechanisms at the molecular level.
Laboratory Applications
Research scientists investigate vardenafil compounds to examine PDE5 enzyme kinetics, vascular smooth muscle relaxation pathways, and nitric oxide signalling cascades. Studies evaluate how PDE5 inhibition affects cellular cGMP concentrations and downstream protein kinase G activation in penile corpus cavernosum tissue models. Comparative analyses with other vardenafil research compounds help elucidate structure-activity relationships and selectivity profiles across different phosphodiesterase isoforms. Cardiovascular researchers also examine vardenafil’s effects on pulmonary arterial smooth muscle cells to understand hemodynamic changes and potential therapeutic mechanisms for pulmonary hypertension models.
In-vitro studies investigate vardenafil’s pharmacological properties including enzyme binding affinity, inhibitory concentration values, and selectivity ratios compared to other phosphodiesterase families. Cell culture experiments evaluate dose-response curves in human umbilical vein endothelial cells and examine how vardenafil influences endothelial nitric oxide synthase expression and activity. Researchers may also conduct comparative studies alongside selective androgen receptor modulators and peptide compounds to understand multi-pathway interactions in complex physiological research models.
Technical Specifications
| Active Compound | Vardenafil |
|---|---|
| Manufacturer | Sunrise Pharmaceuticals |
| Dosage Strength | 40mg per tablet |
| CAS Number | 224785-91-5 |
| Molecular Formula | C₂₃H₃₂N₆O₄S |
| Molecular Weight | 488.60 g/mol |
| Storage Requirements | Room temperature, dry environment |
Research Compliance
Zhewitra-40 Sunrise is manufactured exclusively for in-vitro laboratory research purposes and is not approved for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory protocols, documentation, and safety measures when handling this compound. This product is intended solely for qualified research institutions studying phosphodiesterase inhibition mechanisms, vascular biology, and related scientific investigations under controlled laboratory conditions.
